ZA975889B - HIV envelope polypeptides and vaccine. - Google Patents

HIV envelope polypeptides and vaccine.

Info

Publication number
ZA975889B
ZA975889B ZA9705889A ZA975889A ZA975889B ZA 975889 B ZA975889 B ZA 975889B ZA 9705889 A ZA9705889 A ZA 9705889A ZA 975889 A ZA975889 A ZA 975889A ZA 975889 B ZA975889 B ZA 975889B
Authority
ZA
South Africa
Prior art keywords
vaccine
hiv envelope
envelope polypeptides
polypeptides
hiv
Prior art date
Application number
ZA9705889A
Other languages
English (en)
Inventor
Phillip W Berman
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of ZA975889B publication Critical patent/ZA975889B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • AIDS & HIV (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
ZA9705889A 1996-07-08 1997-07-02 HIV envelope polypeptides and vaccine. ZA975889B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US67673796A 1996-07-08 1996-07-08

Publications (1)

Publication Number Publication Date
ZA975889B true ZA975889B (en) 1998-02-23

Family

ID=24715764

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9705889A ZA975889B (en) 1996-07-08 1997-07-02 HIV envelope polypeptides and vaccine.

Country Status (13)

Country Link
US (1) US6090392A (2)
EP (1) EP0942988A1 (2)
JP (1) JP2000515368A (2)
AP (1) AP1282A (2)
AU (1) AU727107B2 (2)
CA (1) CA2259965A1 (2)
ID (1) ID17767A (2)
IL (2) IL127701A0 (2)
NZ (1) NZ333500A (2)
OA (1) OA10954A (2)
TW (1) TWI221846B (2)
WO (1) WO1998001564A1 (2)
ZA (1) ZA975889B (2)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6562347B1 (en) 1998-03-12 2003-05-13 The United States Of America As Represented By The Department Of Health And Human Services Chemokine-tumor antigen fusion proteins as cancer vaccines
EP1307130A4 (en) 2000-02-04 2005-01-12 Beth Israel Hospital VACCINE AGAINST THE VIRUS OF HUMAN IMMUNODEFICIENCY
AU2001254567A1 (en) * 2000-05-02 2001-11-12 Simon Fraser University Polypeptides for use as a vaccine and/or treatment for hiv infection
US20030228320A1 (en) * 2000-08-18 2003-12-11 Ashdown Martin Leonard Retroviral immunotherapy
AUPS065002A0 (en) 2002-02-20 2002-03-14 Immunaid Pty Ltd Strategy for retroviral immunotherapy
WO2002022687A2 (en) 2000-09-15 2002-03-21 The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Viral chemokine-tumur antigen fusion proteins
WO2002022686A2 (en) 2000-09-15 2002-03-21 The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services, National Institutes Of Health, Office Of Technology Transfer Defensin-antigen fusion proteins
US20060116325A1 (en) * 2001-02-15 2006-06-01 Oleg Chertov Methods and compositions for inhibiting hiv-coreceptor interactions
AUPS054702A0 (en) * 2002-02-14 2002-03-07 Immunaid Pty Ltd Cancer therapy
ES2416629T3 (es) * 2002-12-03 2013-08-02 University Of Massachusetts Vacunas polivalentes de ADN de glicoproteína de VIH-1 primaria y procedimientos de vacunación
US20050025779A1 (en) * 2003-06-12 2005-02-03 Vaxgen, Inc. HIV-1 envelope glycoproteins having unusual disulfide structure
US8076060B2 (en) * 2003-08-04 2011-12-13 Emil William Chynn Vaccination and immunotherapy as new therapeutic modalities in the treatment of glaucoma
EP1692516B1 (en) * 2003-10-24 2010-12-01 Immunaid Pty Ltd Method of therapy
JP5386083B2 (ja) * 2004-09-08 2014-01-15 イミューンネイド ピーティーワイ リミテッド 自己免疫疾患および変性疾患を治療する方法
US9085807B2 (en) * 2004-09-14 2015-07-21 Argos Therapeutics, Inc. Strain-independent amplification of pathogens and vaccines thereto
CA2623197A1 (en) * 2005-09-22 2007-03-29 Prosci Incorporated Glycosylated polypeptides produced in yeast mutants and methods of use thereof
WO2009017743A2 (en) * 2007-07-30 2009-02-05 Argos Therapeutics, Inc. Improved primers and probes for the amplification and detection of hiv gag, rev and nef polynucleotides
WO2009155489A2 (en) 2008-06-19 2009-12-23 Variation Biotechnologies, Inc. Compositions and methods for treating influenza
WO2010135781A1 (en) 2009-05-27 2010-12-02 Immunaid Pty Ltd Methods of treating diseases
AU2010270722B2 (en) 2009-07-06 2015-06-04 Variation Biotechnologies, Inc. Methods for preparing vesicles and formulations produced therefrom
US9907746B2 (en) 2009-07-06 2018-03-06 Variation Biotechnologies, Inc. Methods for preparing vesicles and formulations produced therefrom
EP2550362B1 (en) 2010-03-25 2017-01-04 Oregon Health&Science University Cmv glycoproteins and recombinant vectors
MX342138B (es) 2010-07-06 2016-09-14 Variation Biotechnologies Inc Composiciones y metodos para el tratamiento de influenza.
CA2862864C (en) 2011-01-13 2018-12-11 Variation Biotechnologies Inc. Compositions and methods for treating viral infections
CA2832109C (en) 2011-06-10 2021-07-06 Oregon Health & Science University Cmv glycoproteins and recombinant vectors
EP2568289A3 (en) 2011-09-12 2013-04-03 International AIDS Vaccine Initiative Immunoselection of recombinant vesicular stomatitis virus expressing hiv-1 proteins by broadly neutralizing antibodies
US9402894B2 (en) 2011-10-27 2016-08-02 International Aids Vaccine Initiative Viral particles derived from an enveloped virus
US20140356399A1 (en) 2012-01-12 2014-12-04 Variation Biotechnologies, Inc. Compositions and methods for treating viral infections
US20150079077A1 (en) 2012-01-27 2015-03-19 Variation Biotechnologies, Inc. Methods and compositions for therapeutic agents
EP2679596B1 (en) 2012-06-27 2017-04-12 International Aids Vaccine Initiative HIV-1 env glycoprotein variant
CN104955847A (zh) 2012-12-04 2015-09-30 马里兰州大学(巴尔的摩) HIV-1 Env结合抗体、融合蛋白及其使用方法
EP2848937A1 (en) 2013-09-05 2015-03-18 International Aids Vaccine Initiative Methods of identifying novel HIV-1 immunogens
US10058604B2 (en) 2013-10-07 2018-08-28 International Aids Vaccine Initiative Soluble HIV-1 envelope glycoprotein trimers
EP3069730A3 (en) 2015-03-20 2017-03-15 International Aids Vaccine Initiative Soluble hiv-1 envelope glycoprotein trimers
EP3072901A1 (en) 2015-03-23 2016-09-28 International Aids Vaccine Initiative Soluble hiv-1 envelope glycoprotein trimers

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE138100T1 (de) * 1984-12-24 1996-06-15 Genentech Inc Fusionen von aids-verwandten polypeptiden
ES2102347T3 (es) * 1987-02-20 1997-08-01 Genentech Inc Metodos y composiciones para la utilizacion de polipeptidos env y anticuerpos anti-env de hiv.
IL89118A0 (en) * 1988-02-03 1989-08-15 Microgenesys Inc Vaccine containing polypeptides derived from the envelope gene of human immunodeficiency virus type 1
EP0339504A3 (en) * 1988-04-26 1990-09-12 The Du Pont Merck Pharmaceutical Company Human immunodeficiency virus (hiv) env-coded peptide capable of eliciting hiv-inhibiting antibodies in mammals
US5116740A (en) * 1988-08-16 1992-05-26 Akzo N.V. Method for producing native hiv gp160
AU6523590A (en) * 1989-09-22 1991-04-18 Idec Pharmaceuticals Corporation Novel peptides associated with the cd4 binding region of gp120 and their methods of use
WO1991015238A1 (en) * 1990-04-03 1991-10-17 Genentech, Inc. Methods and compositions for vaccination against hiv
CA2078545A1 (en) * 1990-04-03 1991-10-04 Timothy J. Gregory Hiv envelope polypeptides
EP0708659A4 (en) * 1993-06-07 2000-08-23 Genentech Inc HIV ENVELOPE POLYPEPTIDES

Also Published As

Publication number Publication date
IL127701A (en) 2006-08-01
ID17767A (id) 1998-01-22
CA2259965A1 (en) 1998-01-15
AP1282A (en) 2004-06-09
OA10954A (en) 2001-10-25
AU3567797A (en) 1998-02-02
US6090392A (en) 2000-07-18
JP2000515368A (ja) 2000-11-21
IL127701A0 (en) 1999-10-28
AU727107B2 (en) 2000-11-30
AP9901432A0 (en) 1999-03-31
WO1998001564A1 (en) 1998-01-15
TWI221846B (en) 2004-10-11
EP0942988A1 (en) 1999-09-22
NZ333500A (en) 2000-09-29

Similar Documents

Publication Publication Date Title
ZA975889B (en) HIV envelope polypeptides and vaccine.
EP0708659A4 (en) HIV ENVELOPE POLYPEPTIDES
ZA9811849B (en) Vaccine.
ZA984969B (en) Vaccine.
CZ20011341A3 (cs) Pomocné přípravky a vakciny
EP0611168A3 (en) Hop extract and its use.
CY2433B1 (en) Interferon conjugates.
ZA991662B (en) Recombinant and adjuvant-containing live vaccines.
ZA975533B (en) Cyclosporin-containing pharmaceutical composition.
HUP9802217A3 (en) Recombinant mva virus, and the use thereof
PL331765A1 (en) Trnsplant prosthesis, materials and methods
AU2440997A (en) Calixpyrroles, calixpyridinopyrroles and calixpyridines
EP0958373A4 (en) Vaccines.
ZA976815B (en) Vaccine composition.
ZA975034B (en) Airship.
ZA971663B (en) Porcine reproductive and respiratory syndrome vaccine.
HUP9701586A3 (en) Improved inactivated vaccines
EP0673999A3 (en) Trehalose phosphorylase and its production.
GB9626864D0 (en) Vaccine
ZA969402B (en) Novel oligopeptides, the preparation and use thereof.
ZA9810625B (en) Benzylidenepyrazolones, their preparation and use.
GB2331521B (en) Vaccine preparations
EP0586154A3 (en) Melanin-inhibiting protein, its production and applications.
GB9704977D0 (en) FIV vaccine
ZA9610510B (en) Novel peptides, the preparation and use thereof.